(ANSA) - BRUSSELS, DECEMBER 09 - The data on safety in administering Pfizer-BioNTech's anti-Covid vaccine to children between the ages of 5 and 11 "are reassuring".
The European Medicines Agency (EMA) reports, highlighting that "no safety problems have emerged from the major divaccination campaigns on children" included in this age group "in the United States".
(HANDLE).